A tumor-suppressive microRNA, miRNA-485-5p, inhibits glioma cell proliferation and invasion by down-regulating TPD52L2

被引:4
作者
Yu, Jin [1 ,2 ]
Wu, Shi-Wen [2 ]
Wu, Wei-Ping [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Neurol, 28 Fuxing Rd, Beijing 100853, Peoples R China
[2] Chinese Peoples Armed Police Force, Gen Hosp, Dept Neurol, Beijing, Peoples R China
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2017年 / 9卷 / 07期
关键词
miR-485-5p; glioma; tumorigenesis; proliferation; invasion; HEPATOCELLULAR-CARCINOMA; PROGNOSTIC BIOMARKERS; CANCER-CELLS; MIR-485-5P; METASTASIS; PROGRESSION; GROWTH; IMPACT; ACTS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Glioblastoma multiforme is the most deadly primary brain tumor and has no effective treatment. Therefore, it is important to identify novel and effective therapies that impede glioma tumorigenesis. MicroRNAs (miRNAs) are helpful analytical biomarkers and may be useful targets for treating multiple human cancers. Previous reports suggest that miRNA-485-5p is dysregulated and contributes to tumorigenesis in some cancer types. Nevertheless, the biological role of miRNA-485-5p in glioma is not well understood. In this study, we demonstrated that miRNA-485-5p expression was reduced in gliomat issues and cell lines. In addition, miRNA-485-5p overexpression inhibited cell proliferation, migration, and invasion in glioma cell lines. Additionally, we identified Tumor Protein D52 Like 2 (TPD52L2) as a direct target of miRNA-485-5p. Moreover, we showed that miRNA-485-5p regulated glioma tumorigenesis by down-regulating TPD52L2 expression in vitro and in vivo. Our results suggest that miRNA-485-5p is a suppressor of glioma tumorigenesis and could serve as a novel candidate for therapeutic applications in glioma treatment.
引用
收藏
页码:3336 / 3344
页数:9
相关论文
共 28 条
[1]   miR-485 Acts as a Tumor Suppressor by Inhibiting Cell Growth and Migration in Breast Carcinoma T47D Cells [J].
Anaya-Ruiz, Maricruz ;
Bandala, Cindy ;
Martin Perez-Santos, Jose Luis .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (06) :3757-3760
[2]   Molecular Pathways: microRNAs, Cancer Cells, and Microenvironment [J].
Berindan-Neagoe, Ioana ;
Calin, George A. .
CLINICAL CANCER RESEARCH, 2014, 20 (24) :6247-6253
[3]   MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer [J].
Bertoli, Gloria ;
Cava, Claudia ;
Castiglioni, Isabella .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (03)
[4]   Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy [J].
Cahill, Kirk E. ;
Morshed, Ramin A. ;
Yamini, Bakhtiar .
NEURO-ONCOLOGY, 2016, 18 (03) :329-339
[5]   The emerging roles of microRNAs in cancer metabolism [J].
Chan, Brian ;
Manley, Jacob ;
Lee, Jae ;
Singh, Shree Ram .
CANCER LETTERS, 2015, 356 (02) :301-308
[6]   Prognostic value of Musashi-1 in gliomas [J].
Dahlrot, Rikke H. ;
Hansen, Steinbjorn ;
Herrstedt, Jorn ;
Schroder, Henrik D. ;
Hjelmborg, Jacob ;
Kristensen, Bjarne W. .
JOURNAL OF NEURO-ONCOLOGY, 2013, 115 (03) :453-461
[7]   MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis [J].
Gu, Liangyou ;
Li, Hongzhao ;
Chen, Luyao ;
Ma, Xin ;
Gao, Yu ;
Li, Xintao ;
Zhang, Yu ;
Fan, Yang ;
Zhang, Xu .
ONCOTARGET, 2015, 6 (32) :32545-32560
[8]  
Guo GX, 2015, INT J CLIN EXP PATHO, V8, P12292
[9]   Dysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activity [J].
Gurtner, Aymone ;
Falcone, Emmanuela ;
Garibaldi, Francesca ;
Piaggio, Giulia .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
[10]   miR-485-5p Binding Site SNP rs8752 in HPGD Gene Is Associated with Breast Cancer Risk [J].
He, Na ;
Zheng, Hong ;
Li, Pei ;
Zhao, Yanrui ;
Zhang, Wei ;
Song, Fengju ;
Chen, Kexin .
PLOS ONE, 2014, 9 (07)